サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1360075

南米の臨床試験イメージング市場の2028年までの予測-地域別分析：モダリティ、オファリング、エンドユーザー別

South America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 107 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
南米の臨床試験イメージング市場の2028年までの予測-地域別分析：モダリティ、オファリング、エンドユーザー別
出版日: 2023年07月27日
発行: The Insight Partners
ページ情報: 英文 107 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

南米の臨床試験イメージング市場は、2023年の8,963万米ドルから2028年には1億2,352万米ドルに成長すると予測され、2023年から2028年までのCAGRは6.6%と推定されます。

医療画像サービスを提供するCRO数の急増が南米の臨床試験画像市場を後押し

臨床研究機関（CRO）は、高品質な施設と深い専門知識を駆使して提供するサービスを通じて、臨床試験の成功を支援しています。CROは、効率的で費用対効果の高い業務を通じて治験依頼者に利益をもたらし、臨床試験業界の屋台骨として機能し始めています。例えば、CROが臨床試験を実施し完了するまでに要する時間は、社内活動よりも平均して30％短いです。CROの数が増加し競争が激しくなる中、イメージングに特化したサービスを提供し、イメージングCRO（iCRO）として台頭している企業もあります。Keosys Medical ImagingやMedica Group PLCがiCROの例です。CROは、イメージング実施施設の認定、標準化された画像の取得、読影デザインと基準の決定などの分野で重要な知識を提供し、南米の臨床試験イメージング市場全体の成長に貢献しています。

南米の臨床試験イメージング市場の概要

南米の臨床試験イメージング市場は、アルゼンチン、ブラジル、その他南米に区分されます。ブラジルは2022年に最大のシェアを占め、予測期間中にCAGR 7.2%を記録する見込みです。臨床試験の増加、市場参入企業による主要技術革新、臨床試験イメージングを支援する政府の取り組みなどが市場成長を後押しする要因です。ブラジルは臨床試験の主要な目的地です。Clinical Trials Arenaによると、2021年、ブラジルは世界の臨床試験活動の1.7%のシェアを占めています。2022年7月、ボストンCROはリオデジャネイロを拠点とするこの地域最大の研究センターであるInstituto Brasil de Pesquisa Clinica（IBPClin）を買収し、ラテンアメリカが分散型臨床試験提供モデルを採用する第一歩となったとしています。IBPClinは、ブラジルの12州で7,000人以上の参加者を登録し、160以上の業界主催の調査を実施したとしています。

南米の臨床試験イメージング市場の収益と2028年までの予測（金額）

南米の臨床試験イメージング市場のセグメンテーション

南米の臨床試験イメージング市場は、モダリティ、オファリング、エンドユーザー、国別に区分されます。モダリティベースでは、南米の臨床試験イメージング市場は断層撮影、磁気共鳴画像法（MRI）、超音波、陽電子放射断層撮影法（PET）、X線、心エコー、その他に区分されます。2023年には、断層撮影セグメントが最大の市場シェアを記録しました。

南米の臨床試験イメージング市場は、提供サービスに基づき、運用イメージングサービス、イメージングソフトウェア、読み取り解析サービス、試験デザインおよびコンサルティングサービス、その他に区分されます。オペレーショナルイメージングサービスセグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別に見ると、南米の臨床試験イメージング市場は、受託研究機関（CRO）、製薬・バイオテクノロジー企業、学術・研究機関、その他に区分されます。2023年には、受託研究機関（CRO）セグメントが最大の市場シェアを占めています。

国別に見ると、市場はアルゼンチン、ブラジル、その他南米に区分されます。ブラジルが2023年の市場シェアを独占しました。

eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、VIDA Diagnostics Inc、WCG Clinical Incが南米臨床試験イメージング市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 南米の臨床試験イメージング市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 南米の臨床試験イメージング市場- 市場情勢

    • 南米のPEST分析
  • 専門家の見解

第5章 南米の臨床試験イメージング市場：主要市場力学

  • 市場促進要因
    • 製薬・バイオテクノロジー業界における臨床試験活動の加速
    • メディカルイメージングサービスを提供するCRO数の急増
  • 市場抑制要因
    • 高額投資と標準化されたインフラ要件
  • 市場機会
    • インシリコイメージング臨床試験
  • 今後の動向
    • AI主導型臨床試験
  • インパクト分析

第6章 南米臨床試験イメージング市場

  • 南米の臨床試験イメージング市場の収益と予測分析

第7章 南米の臨床試験イメージング市場の収益と2028年までの予測-モダリティ別

  • 南米の臨床試験イメージング市場のモダリティ別収益シェア（2022年、2028年）
  • トモグラフィ
  • 超音波
  • ポジトロン断層撮影
  • X線
  • 心エコー
  • 磁気共鳴画像法
  • その他

第8章 南米の臨床試験イメージング市場の収益と2028年までの予測-提供

  • 南米の臨床試験イメージング市場のオファリング別収益シェア（2022年および2028年）
  • 臨床試験デザインコンサルティングサービス
  • 読影分析サービス
  • イメージング運用サービス
  • イメージング・ソフトウェア
  • その他

第9章 南米の臨床試験イメージング市場の収益と2028年までの予測-エンドユーザー別

  • 製薬会社およびバイオ製薬会社
  • 契約研究機関
  • 学術・研究機関
  • その他

第10章 南米の臨床試験イメージング市場：収益と2028年までの予測：国別分析

    • 南米
      • ブラジル
      • アルゼンチン
      • その他南米

第11章 南米の臨床試験イメージング市場南米の臨床試験イメージング市場：業界情勢

  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • eResearch Technology Inc
  • ICON PLC
  • VIDA Diagnostics Inc
  • WCG Clinical Inc
  • Medical Metrics Inc
  • IXICO plc

第13章 付録

図表

List Of Tables

  • Table 1. South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Brazil Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Brazil Clinical Trial Imaging Market, by End Use- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Argentina Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Argentina Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Argentina Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Rest of South America Clinical Trial Imaging Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Rest of South America Clinical Trial Imaging Market, by Offering- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Rest of South America Clinical Trial Imaging Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Recent Inorganic Growth Strategies in the Clinical Trial Imaging Market
  • Table 12. Recent Organic Growth Strategies in Clinical Trial Imaging Market
  • Table 13. Glossary of Terms

List Of Figures

  • Figure 1. South America Clinical Trial Imaging Market Segmentation
  • Figure 2. South America Clinical Trial Imaging Market by Country
  • Figure 3. South America Clinical Trial Imaging Market Overview
  • Figure 4. South America Clinical Trial Imaging Market, By Modality
  • Figure 5. South America Clinical Trial Imaging Market, By Country
  • Figure 6. South America: PEST Analysis
  • Figure 7. South America Clinical Trial Imaging Market: Impact Analysis of Drivers and Restraints
  • Figure 8. South America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • Figure 9. Tomography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 10. Ultrasound: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. PET: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. X-Ray: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Echocardiography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Magnetic Resonance Imaging: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. South America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • Figure 17. Trial Design Consulting Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Read Analysis Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Operational Imaging Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Imaging Software: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. South America Clinical Trial Imaging Market Revenue Share, by End User (2022 and 2028)
  • Figure 23. Pharmaceutical and Biopharmaceutical Companies: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Contract Research Organizations: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Academic and Research Institutes: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. South America: Clinical Trial Imaging Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 28. Brazil Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Argentina Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Rest of South America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028658

The South America clinical trial imaging market is expected to grow from US$ 89.63 million in 2023 to US$ 123.52 million by 2028; it is estimated to register a CAGR of 6.6% from 2023 to 2028.

Spur in Number of CROs Offering Medical Imaging Services Fuels South America Clinical Trial Imaging Market

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on an average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, some of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). Keosys Medical Imaging and Medica Group PLC are the iCROs examples. The CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall South America clinical trial imaging market.

South America Clinical Trial Imaging Market Overview

The South America clinical trial imaging market is segmented into Argentina, Brazil, and the Rest of South America. Brazil held the largest share in 2022, and it is expected to register a CAGR of 7.2% during the forecast period. A rise in clinical trials, key innovation by market players, and government initiatives to support clinical trial imaging are a few factors fueling the market growth. Brazil is a major destination for clinical trials. According to Clinical Trials Arena, in 2021, Brazil accounted for 1.7% share of the global clinical trials activity. In July 2022, Boston CRO acquired Rio de Janeiro-based Instituto Brasil de Pesquisa Clinica (IBPClin), the largest research center in the region, describing it as the first step towards Latin America's adoption of its decentralized clinical trial delivery model. It claims to have conducted more than 160 industry-sponsored research studies, enrolling more than 7,000 participants across 12 Brazilian states.

South America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)

South America Clinical Trial Imaging Market Segmentation

The South America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country. Based on modality, the South America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.

Based on offering, the South America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.

Based on end user, the South America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.

Based on country, the market is segmented into Argentina, Brazil, and the Rest of South America. Brazil dominated the market share in 2023.

eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the South America clinical trial imaging market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America clinical trial imaging market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
  • develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 South America Market Segmentation
    • 1.3.1 South America Clinical Trial Imaging Market - by Modality
    • 1.3.2 South America Clinical Trial Imaging Market - by Offering
    • 1.3.3 South America Clinical Trial Imaging Market - by End User
    • 1.3.4 South America Clinical Trial Imaging Market - by Country

2. South America Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South America Clinical Trial Imaging Market - Market Landscape

  • 4.1 Overview
    • 4.1.1 South America PEST Analysis
  • 4.2 Expert Opinion

5. South America Clinical Trial Imaging Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
    • 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
  • 5.2 Market Restraints
    • 5.2.1 High Investment and Standardized Infrastructure Requirements
  • 5.3 Market Opportunities
    • 5.3.1 In-Silico Imaging Clinical Trials
  • 5.4 Future Trends
    • 5.4.1 AI-Driven Clinical Trials
  • 5.5 Impact Analysis

6. South America Clinical Trial Imaging Market

  • 6.1 South America Clinical Trial Imaging Market Revenue Forecast and Analysis

7. South America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

  • 7.1 Overview
  • 7.2 South America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
  • 7.3 Tomography
    • 7.3.1 Overview
    • 7.3.2 Tomography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Ultrasound
    • 7.4.1 Overview
    • 7.4.2 Ultrasound: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Positron Emission Tomography
    • 7.5.1 Overview
    • 7.5.2 PET: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 X-Ray
    • 7.6.1 Overview
    • 7.6.2 X-Ray: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.7 Echocardiography
    • 7.7.1 Overview
    • 7.7.2 Echocardiography: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.8 Magnetic Resonance Imaging
    • 7.8.1 Overview
    • 7.8.2 Magnetic Resonance Imaging: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. South America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

  • 8.1 Overview
  • 8.2 South America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
  • 8.3 Trial Design Consulting Services
    • 8.3.1 Overview
    • 8.3.2 Trial Design Consulting Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Read Analysis Services
    • 8.4.1 Overview
    • 8.4.2 Read Analysis Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Operational Imaging Services
    • 8.5.1 Overview
    • 8.5.2 Operational Imaging Services: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Imaging Software
    • 8.6.1 Overview
    • 8.6.2 Imaging Software: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. South America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

  • 9.1 Overview
  • 9.2 Pharmaceutical and Biopharmaceutical Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biopharmaceutical Companies: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.3 Contract Research Organizations
    • 9.3.1 Overview
    • 9.3.2 Contract Research Organizations: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Academic and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academic and Research Institutes: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. South America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 South America: Clinical Trial Imaging Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
      • 10.1.1.2 Overview
        • 10.1.1.2.1 Brazil: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.2 Brazil: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.1.2.3 Brazil: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.1.2.4 Brazil: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.1.3 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Argentina: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.2 Argentina: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.1.3.3 Argentina: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.1.3.4 Argentina: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
      • 10.1.1.4 Rest of South America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Rest of South America: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.2 Rest of South America: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.1.4.3 Rest of South America: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
        • 10.1.1.4.4 Rest of South America: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. South America Clinical Trial Imaging Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Inorganic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 eResearch Technology Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 ICON PLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 VIDA Diagnostics Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 WCG Clinical Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Medical Metrics Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 IXICO plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms